Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study

NCT06914908 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06914908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
May 12, 2025
Completion date
January 29, 2031
Enrollment
71 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps